Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.77M Sell
40,167
-25,514
-39% -$2M ﹤0.01% 2600
2014
Q2
$5.38M Sell
65,681
-47,329
-42% -$3.21M ﹤0.01% 1896
2014
Q1
$7.65M Sell
113,010
-16,193
-13% -$1.2M 0.01% 1472
2013
Q4
$9.2M Buy
129,203
+28,395
+28% +$2.2M 0.01% 1318
2013
Q3
$7.7M Buy
100,808
+57,720
+134% +$4M 0.01% 1336
2013
Q2
$2.8M Buy
+43,088
New +$2.31M ﹤0.01% 2182

Other funds holding PRLB

UBS's PRLB Position: Q3 2014 in Review

UBS reduced its Protolabs (PRLB) stake by 39% in Q3 2014, selling an estimated $2M and leaving 40,167 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

UBS first reported a position in PRLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.2M in Q4 2013. 187 funds tracked by Wall St. Rank hold PRLB as of Q3 2014.

  • UBS held 40,167 shares of Protolabs worth $2.77M as of Q3 2014.
  • UBS sold 25,514 Protolabs shares in Q3 2014, an estimated $2M.
  • Protolabs made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2600 holding.
  • UBS first reported a position in Protolabs in Q2 2013 and has held it in 6 quarters since.
  • UBS's Protolabs position peaked at $9.2M in Q4 2013.
  • 187 funds tracked by Wall St. Rank held Protolabs as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.